Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise

Size: px
Start display at page:

Download "Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise"

Transcription

1 Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise Nancy J. Pluhowski Director, Office of the Center Director Center for Devices and Radiological Health (CDRH), FDA Stanford University A Total Product Lifecycle Approach to Medical Device Development: Responsibilities and Opportunities September 2010

2 Disclaimer This communication does not constitute a written advisory opinion under 21 CFR 10.85, but rather is an informal communication under 21 CFR 10.85(k) which represents the best judgment of the employee providing it. This information does not necessarily represent the formal position of FDA, and does not bind or otherwise obligate or commit the agency to the views expressed. September,

3 CDRH (EEP): What We Do in EEP EEP provides guidance and assistance to CDRH to: Identify the needs for expertise within CDRH Foster collaborations with experts in the medical community and academic institutions to fulfill expertise needs Establish technology transfer agreements to develop and formalize partnerships Administer the Critical Path Program within CDRH September,

4 Outline for Presentation Fellowship Programs CDRH s Medical Device Fellowship Program (MDFP) FDA Commissioner s Fellowship Program (CFP) FDA s Critical Path Program September,

5 Medical Device Fellowship Program (MDFP) EEP uses MDFP to expand CDRH s capacity to obtain the expertise required to regulate medical devices of ever-increasing complexity September,

6 Expertise at CDRH acquired through MDFP includes: Cardiothoracic Surgery Interventional Cardiology Electrophysiology Neurosurgery Pulmonology Gastroenterology Ophthalmology Internal Medicine Nephrology Plastic Surgery Psychiatry Orthopedic Surgery Obstetrician and Gynecology Biomedical Engineering Biology Chemistry Epidemiology Biostatistics Regulatory Law September,

7 Academic Institutions Fellows have come to CDRH from: Stanford University Harvard University Johns Hopkins University Cleveland Clinic University of Pittsburgh George Washington University University of Texas Health Sciences Center William and Mary Mayo Clinic University of North Carolina Syracuse University University of Maryland September,

8 MDFP Fellows from Stanford Univ. Project examples: Computational modeling for cardiovascular devices Applying regulatory device processes to dental amalgam MDFP Intern Projects September,

9 MDFP Fellows from Stanford Univ. Computational Modeling for Cardiovascular Devices CDRH in collaboration with Stanford, NHLBI, and NSF held a Critical Path Workshop on Use of Computational Modeling Techniques for Cardiovascular Device Development which identified the current challenges for this important area of cardiovascular medical device development September,

10 MDFP Fellows from Stanford Univ. Apply Regulatory Processes to Dental Amalgam Research and analyze comments from a 2002 proposed rule on dental amalgam Review and summarize comments from a 2008 Federal Register Notice of final rule on dental amalgam Serve as a medical device reviewer in the Dental Devices Branch September,

11 MDFP Fellows from Stanford Univ. Intern Project (example) Analyze adverse reports in the MAUDE database to help identify any specific issues related to the use of surgical mesh. The data will be analyzed for trends to determine patterns in specific product characteristics or categories that contribute significantly to adverse events September,

12 MDFP Fellows from Stanford Univ. Intern Project (example) Analyze adverse event data of MRI related thermal injuries, develop a scientific rationale for the occurrences, and determine suitable preventative measures September,

13 MDFP Fellows from Stanford Univ. Intern Project (example) Evaluate partnership opportunities in EEP and develop collaboration policy statements to help support public health initiatives Collect and analyze data from sources associated with each area of EEP - Critical Path, MDFP and Tech Transfer September,

14 Commissioner s Fellowship Program at FDA Engineering Candidates may have BS, MS, PhD or but all other candidates must have MD or PhD level Combination of project and required course work All fellows start as a cohort in October of each year Application period is January to March Website - go to find this link: uatefacultyprograms/commissionersfellowshipprogram/default.htm Or, search for CDRH preceptors to find a list of CDRH preceptors September,

15 Critical Path (CP) Program The goal of FDA s Critical Path Program is to identify and prioritize the most pressing problems in medical product development and the greatest opportunities for improvement in public health benefits Critical Path Opportunities Report path/ September,

16 Examples of CDRH CP Projects Leverage the Simulation-Based Engineering and Medical Imaging Technology GOAL: Promote the use of computational modeling in cardiovascular device design and address barriers and regulatory issues needed to implement modeling September,

17 Examples of CDRH CP Projects Conduct research to ultimately standardize CT Protocols for Imaging-based Measures of Disease Status in Lung Cancer GOAL: Improved use of CT for evaluating effect of therapy and drug trials for lung cancer September,

18 Examples of CDRH CP Projects Biomarkers of Acute Kidney Injury to Improve Public Health and Product Approval GOAL: Development of new biomarkers to detect acute kidney injury previous biomarkers detected damage when injury was severe September,

19 Examples of CDRH CP Projects Standardize Assessment of Impingement in Spinal Devices GOAL: Develop and validate impingement testing to better predict device success September,

20 Thank you! External Expertise and Partnerships Technology Transfer Medical Device Fellowship Program Critical Path Initiative

Pediatric Drug Development: Successes and Challenges

Pediatric Drug Development: Successes and Challenges Pediatric Drug Development: Successes and Challenges Lynne Yao, M.D. Director, Division of Pediatric and Maternal Health Office of New Drugs Center for Drug Evaluation and Research U.S. FDA September 23,

More information

Global Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA

Global Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA Global Pediatric Development: We Are Making Progress PMDA Perspective Junko Sato, PhD PMDA Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter

More information

GDUFA: 2 ½ years later Impact & Importance

GDUFA: 2 ½ years later Impact & Importance GDUFA: 2 ½ years later Impact & Importance Georgia Hizon Manager, Regulatory Publications Fresenius Kabi USA, LLC Disclaimer The views and opinions expressed in the following PowerPoint slides are those

More information

HIV and Drug Use Research Fellowship. Programme and Application Webinar

HIV and Drug Use Research Fellowship. Programme and Application Webinar HIV and Drug Use Research Fellowship Programme and Application Webinar Programme and Application Webinar HIV and Drug Use Research Fellowship Programme Intersection of HIV and Drug Use Objectives and Expected

More information

Introduction and Workshop Objectives

Introduction and Workshop Objectives Introduction and Workshop Objectives FDA-UMD CERSI on Pediatric Extrapolation Lily Mulugeta, PharmD Office of Clinical Pharmacology Office of Translational Sciences CDER US FDA Disclaimer: The opinions

More information

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA. Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA (Laser Notice 51) Document issued on: May 27, 2001 U.S. Department of Health

More information

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program Andrea Leonard-Segal, M.D., M.S. Director, Division of Nonprescription Clinical Evaluation 1 Contents

More information

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium COMMENTS on a draft Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products Chemistry, Manufacturing, and Controls Documentation (Docket No. 99D-1454) Submitted by

More information

REVIEW MANAGEMENT. Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS

REVIEW MANAGEMENT. Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS REVIEW MANAGEMENT Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS PURPOSE BACKGROUND REFERENCES DEFINITIONS AND ACRONYMS POLICY PROCEDURES EFFECTIVE DATE PURPOSE This MAPP describes: The

More information

Committed to Environment, Health, & Safety

Committed to Environment, Health, & Safety Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,

More information

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network Strategic Operational Research Plan 2017-2018 February 13, 2017 Digestive Health Strategic Clinical Network DH SCN Strategic Operational Plan The of the Digestive Health Strategic Clinical Network The

More information

QUESTIONS & ANSWERS: PRACTISING DENTAL HYGIENISTS and STUDENTS

QUESTIONS & ANSWERS: PRACTISING DENTAL HYGIENISTS and STUDENTS ENTRY-TO-PRACTICE COMPETENCIES AND STANDARDS FOR CANADIAN DENTAL HYGIENISTS QUESTIONS & ANSWERS: PRACTISING DENTAL HYGIENISTS and STUDENTS Canadian Dental Hygienists Association The ETPCS: Q&A attempts

More information

The European Board of Urology

The European Board of Urology Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal

More information

Background. Historical Context

Background. Historical Context Background In order to use prescription medications safely, consumers need to receive clear, actionable information. This medication information must be accurate, balanced, and delivered in a consistent

More information

Consultant Services to Kansas Family Physicians

Consultant Services to Kansas Family Physicians Consultant Services to Kansas Family Physicians The purpose of this study is to track the use of consultants. An e-mail survey was sent to 114 Kansas family physicians The survey was launched on 11/25/2009

More information

Scope of Practice for the Diagnostic Ultrasound Professional

Scope of Practice for the Diagnostic Ultrasound Professional Scope of Practice for the Diagnostic Ultrasound Professional Copyright 1993-2000 Society of Diagnostic Medical Sonographers, Dallas, Texas USA: All Rights Reserved Worldwide. Organizations which endorse

More information

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing;

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing; 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 15 [Docket No. FDA-2013-N-0402] Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public

More information

The Reprocessing of Single- Use Medical Devices; Regulations Coming to Europe? CleanMed Europe Malmo, Sweden 26 September 2012

The Reprocessing of Single- Use Medical Devices; Regulations Coming to Europe? CleanMed Europe Malmo, Sweden 26 September 2012 1 The Reprocessing of Single- Use Medical Devices; Regulations Coming to Europe? CleanMed Europe Malmo, Sweden 26 September 2012 2 Topics to be Covered Introduction to AMDR Introduction to single-use medical

More information

INTERNATIONAL NUCLEAR SAFEGUARDS ENGAGEMENT PROGRAM. National Nuclear Security Administration. Nuclear Safeguards

INTERNATIONAL NUCLEAR SAFEGUARDS ENGAGEMENT PROGRAM. National Nuclear Security Administration. Nuclear Safeguards 2017 INTERNATIONAL NUCLEAR SAFEGUARDS ENGAGEMENT PROGRAM National Nuclear Security Administration Nuclear Safeguards 1 Contents 1 2 4 6 The International Nuclear Safeguards Engagement Program About IAEA

More information

Application of Bayesian Extrapolation in Pediatric Drug Development Program

Application of Bayesian Extrapolation in Pediatric Drug Development Program Application of Bayesian Extrapolation in Pediatric Drug Development Program May Mo, Amy Xia Amgen Regulatory-Industry Statistics Workshop Sep 13, 2018 Washington, DC Disclaimer: The views expressed herein

More information

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Report of the Council on Ethics, Bylaws and Judicial Affairs on Advisory Opinion 5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Ethical Advertising under ADA Code:

More information

Clinical Endpoint Bioequivalence Study Review in ANDA Submissions. Ying Fan, Ph.D.

Clinical Endpoint Bioequivalence Study Review in ANDA Submissions. Ying Fan, Ph.D. Clinical Endpoint Bioequivalence Study Review in ANDA Submissions Ying Fan, Ph.D. 1 Disclaimer This presentation constitutes an informal communication that represents the best judgment of the speaker at

More information

Use of Standards in Substantial Equivalence Determinations

Use of Standards in Substantial Equivalence Determinations Guidance for Industry and for FDA Staff Use of Standards in Substantial Equivalence Determinations Document issued on: March 12, 2000 U.S. Department Of Health And Human Services Food and Drug Administration

More information

Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies.

Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies. THE POWER OFx MEDPACE ADVANTAGE FOR LIPID STUDIES Experts. Experience. Execution. Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development

More information

By Laws: Spinal Cord Injury Research Fund Board Board Approval May 2, 2014

By Laws: Spinal Cord Injury Research Fund Board Board Approval May 2, 2014 By Laws: Spinal Cord Injury Research Fund Board Board Approval May 2, 2014 Background/History: The South Carolina Spinal Cord Injury Research Fund (SCIRF) was established in 2000 by amendment (Bill S54

More information

Mercy Health Corporation (WI)

Mercy Health Corporation (WI) Mercy Health Corporation (WI) 1 Illinois Finance Authority, Revenue Bonds (Mercy Health Corporation), Series, $475,020,000, Dated: May 18, 2 Wisconsin Health and Educational Facilities Authority, Revenue

More information

SullivanCotter 2012 Physician Compensation and Productivity Survey

SullivanCotter 2012 Physician Compensation and Productivity Survey Physician Practice Areas Anesthesiology Anesthesiology Critical Care Anesthesiology Pain Medicine Anesthesiology Pediatric Anesthesiology Cardiology Cardiac Imaging (Echo, CT/MRI, Nuclear) Electrophysiology

More information

5 American Journal of Kidney Diseases Elsevier NEPHROLOGY Science Direct

5 American Journal of Kidney Diseases Elsevier NEPHROLOGY Science Direct 1 Acta Pharmacologica Sinica Publishing 2 Adolescent Psychiatry Psychiatry 3 American Heart Journal Elsevier CARDIOLOGY Science Direct 4 American Journal of Gastroenterology Publishing 5 American Journal

More information

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Document issued on: November 12, 2002 This document supersedes the

More information

Integration of Specialty Care into ACOs: Considering JMAP and Beyond

Integration of Specialty Care into ACOs: Considering JMAP and Beyond Integration of Specialty Care into ACOs: Considering JMAP and Beyond The Seventh National Accountable Care Organization Summit Scott A. Berkowitz MD MBA Senior Medical Director, Accountable Care, Johns

More information

AAP Immunization Initiatives JILL HERNANDEZ, MPH

AAP Immunization Initiatives JILL HERNANDEZ, MPH AAP Immunization Initiatives JILL HERNANDEZ, MPH AAP Structure The AAP Today 62,000 members 10 districts 66 state/local chapters 26 national committees 50 sections 11 councils 500 staff Illinois, Washington

More information

Regulatory interactions: Expectations on extrapolation approaches

Regulatory interactions: Expectations on extrapolation approaches Regulatory interactions: Expectations on extrapolation approaches Lynne Yao, M.D. Director, Division of Pediatric and Maternal Health Office of New Drugs Center for Drug Evaluation and Research U.S. Food

More information

Using and Referencing ISO and IEC Standards for Technical Regulation

Using and Referencing ISO and IEC Standards for Technical Regulation Using and Referencing ISO and IEC Standards for Technical Regulation Third ANSI Conference on U.S. Leadership in ISO and IEC May 23-24, 24, 2007 Chicago, IL David P. Kelly, M.I.M. Office of International

More information

Basic Standards for Fellowship Training in Sleep Medicine

Basic Standards for Fellowship Training in Sleep Medicine Basic Standards for Fellowship Training in Sleep Medicine American Osteopathic Association and American College of Osteopathic Neurologists and Psychiatrists and American College of Osteopathic Internists

More information

I-1 TIME SERIES - MOST RECENT FIVE YEARS Field of post-m.d. training and source of funding

I-1 TIME SERIES - MOST RECENT FIVE YEARS Field of post-m.d. training and source of funding Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Pain Medicine (Anes.) Public Health

More information

Curriculum Vitae. EDUCATION M.S. Biomedical Engineering, University of Alabama Birmingham (1992) B.S. Biomedical Engineering, Tulane University (1989)

Curriculum Vitae. EDUCATION M.S. Biomedical Engineering, University of Alabama Birmingham (1992) B.S. Biomedical Engineering, Tulane University (1989) Curriculum Vitae Angela Blackwell, M.S. angela@blackwelldevice.com Senior Consultant Blackwell Device Consulting. Portland, OR EDUCATION M.S. Biomedical Engineering, University of Alabama Birmingham (1992)

More information

Introduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:

Introduction. Current status of 510(k) clinical data requirements. 1   Current Status&Considerations: 510(k) Current Status&Considerations: Conducting a Well-Controlled Clinical Study When Clinical Data is Required Introduction In an effort to promote innovation while protecting the population at large,

More information

Council of Pediatric Subspecialties: CoPS April Jim Bale, MD Chair, CoPS

Council of Pediatric Subspecialties: CoPS April Jim Bale, MD Chair, CoPS Council of Pediatric Subspecialties: CoPS April 2012 Jim Bale, MD Chair, CoPS Background Founded in 2006 to standardize entry into Pediatric Fellowships Charged by AMSPDC to focus on fellowship training

More information

PMDA Considerations for Outcome Assessments

PMDA Considerations for Outcome Assessments PMDA Considerations for Outcome Assessments Keiju Motohashi Office of New Drug II Pharmaceuticals and Medical Devices Agency/ The University of Tokyo Hospital Disclaimer The views and opinions expressed

More information

NASH Regulatory Landscape. Veronica Miller, PhD Forum for Collaborative Research UC Berkeley SPH

NASH Regulatory Landscape. Veronica Miller, PhD Forum for Collaborative Research UC Berkeley SPH NASH Regulatory Landscape Veronica Miller, PhD Forum for Collaborative Research UC Berkeley SPH Disclosures Liver Forum sponsors (last slides) Advisory (Sanofi) Miller_July 7_2017 www.forumresearch.org

More information

Agenda: Dental Cone Beam Imaging

Agenda: Dental Cone Beam Imaging Cone Beam Imaging Agenda: Dental Cone Beam Imaging *Definition and Functionality *Usage and diagnostics benefits *Comparative radiation information *Federal regulatory responsibilities: manufacturing *State

More information

Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective

Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective John W. Metcalfe, Ph.D. Senior Review Microbiologist FDA/CDER/OPQ/OPF/Division of Microbiology Assessment Center for Drug Evaluation

More information

Annual Review of Pathology: Mechanisms of Disease Annual Review Pathology 2011-till date

Annual Review of Pathology: Mechanisms of Disease Annual Review Pathology 2011-till date ANNUAL REVIEWS Sl.No. Title of the Journal Publisher Subject Speciality Period 1 Annual Review of Analytical Chemistry Annual Review Biochemistry 2011-till date 2 Annual Review of Biochemistry Annual Review

More information

Comprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP

Comprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP Comprehensive Cancer Control Technical Assistance Training and Communication Plan PI: Mandi Pratt-Chapman, MA Cooperative Agreement #1U38DP004972-01 July 2014 Acknowledgement: This work was supported by

More information

Obesity Medicine: Building Credibility and Seeking Certification in a Stigmatized Field

Obesity Medicine: Building Credibility and Seeking Certification in a Stigmatized Field Obesity Medicine: Building Credibility and Seeking Certification in a Stigmatized Field Dana Brittan, MBA, American Board of Obesity Medicine (ABOM) Robert Kushner, MD, Northwestern University Feinberg

More information

ADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development

ADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development ADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development Wm Z Potter, MD, PhD Sr. Advisor, NIMH IOM, Nov 15, 2014 Disclosures Former employee of Lilly

More information

Letter to the AMGA Board of Directors...1 Introduction...3

Letter to the AMGA Board of Directors...1 Introduction...3 Table of Contents Letter to the AMGA Board of Directors...1 Introduction...3 Section I: Executive Summary Survey at a Glance...6 Participant Profile...10 Survey Methodology...18 How to Use This Report...21

More information

Basic Standards for Osteopathic Fellowship Training in Sleep Medicine

Basic Standards for Osteopathic Fellowship Training in Sleep Medicine Basic Standards for Osteopathic Fellowship Training in Sleep Medicine American Osteopathic Association and the American College of Osteopathic Neurologists and Psychiatrists and the American College of

More information

Table 1 ABMS MEMBER BOARDS APPROVED GENERAL CERTIFICATES

Table 1 ABMS MEMBER BOARDS APPROVED GENERAL CERTIFICATES Table 1 ABMS MEMBER BOARDS APPROVED GENERAL CERTIFICATES A general certificate is the first certification awarded by a Member Board to candidates who meet the requirements for board certification in a

More information

NIH Initiatives in Nutrition: Roadmap, Strategic Plan

NIH Initiatives in Nutrition: Roadmap, Strategic Plan NIH Initiatives in Nutrition: Roadmap, Strategic Plan Paul M. Coates, Ph.D. DC IFT Food Policy Impact 2017 National Nutrition Research Roadmap: NIH Initiatives How does the NIH address nutrition research

More information

Tuberous Sclerosis Complex Research Program

Tuberous Sclerosis Complex Research Program Tuberous Sclerosis Complex Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military,

More information

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory This document is scheduled to be published in the Federal Register on 03/01/2018 and available online at https://federalregister.gov/d/2018-04167, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Better Partner Health

Better Partner Health 4 Better Partner Health Building strategic partnerships with like-minded organizations, companies and government bodies better positions Mylan to reach patients and achieve our mission. From R&D to manufacturing

More information

Charlie Norwood VA Medical Center. Robert U. Hamilton, FACHE Medical Center Director

Charlie Norwood VA Medical Center. Robert U. Hamilton, FACHE Medical Center Director Charlie Norwood VA Medical Center Robert U. Hamilton, FACHE Medical Center Director 1 One VA Three Branches The Honorable Eric K. Shinseki The Honorable Robert A. Petzel, MD Under Secretary for Health

More information

Specialty-specific References for DIOs: Expected Time for Coordinator

Specialty-specific References for DIOs: Expected Time for Coordinator Allergy and Immunology Anesthesiology Adult Cardiothoracic Anesthesiology Anesthesiology Critical Care Obstetric Anesthesiology Anesthesiology Regional Anesthesiology and Acute Pain Specialty-specific

More information

Appendix A Residents and Fellows Cardiopulmonary Resuscitation (CPR) Certification Requirements by Program

Appendix A Residents and Fellows Cardiopulmonary Resuscitation (CPR) Certification Requirements by Program Appendix A Residents and Fellows Cardiopulmonary Resuscitation (CPR) Certification Requirements by Program PROGRAM Type RESIDENT BLS ACLS PALS NRP ATLS Allergy & Immunology Fellow X X X Anesthesia Dentistry

More information

September 20, Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201

September 20, Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201 September 20, 2001 Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201 Dear Mr. Scully: The medical organizations listed below would like

More information

Straub Clinic and Hospital Implementation Strategy Plan. May 2013

Straub Clinic and Hospital Implementation Strategy Plan. May 2013 Straub Clinic and Hospital Implementation Strategy Plan May 2013 Table of Contents 1 Introduction... 1 2 Community Served by Straub Clinic and Hospital... 2 3 Community Benefit Planning Process... 3 3.1

More information

The Telemetric and Holter ECG Warehouse (THEW) Initiative

The Telemetric and Holter ECG Warehouse (THEW) Initiative The Telemetric and Holter ECG Warehouse (THEW) Initiative Jean-Philippe Couderc, PhD THEW HRFUP- Cardiology University of Rochester Medical Center, NY Mission Statement The objective of the Telemetric

More information

Association of American Cancer Institutes

Association of American Cancer Institutes Association of American Cancer Institutes Statement by the Association of American Cancer Institutes on Fiscal Year (FY) 2016 Appropriations for the Department of Health and Human Services Subcommittee

More information

The EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn,

The EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn, The EU PIP - a step in Pediatric Drug Development Thomas Severin Bonn, 13.01.2009 Agenda Implications for Industry Company Preparation Time of PIP Submission Content of the PIP The PIP Process and first

More information

Specific Standards of Accreditation for Residency Programs in Adult and Pediatric Neurology

Specific Standards of Accreditation for Residency Programs in Adult and Pediatric Neurology Specific Standards of Accreditation for Residency Programs in Adult and Pediatric Neurology INTRODUCTION 2011 A university wishing to have an accredited program in adult Neurology must also sponsor an

More information

Ovid-Lippincott Journals

Ovid-Lippincott Journals A&A Case Reports 2325-7237 http://ovidsp.ovid.com/ovidweb.cgi?t=js&news=n&csc=y&page=toc&d=yrovft&an=01720097-000000000-00000 Academic Medicine 1040-2446 http://ovidsp.ovid.com/ovidweb.cgi?t=js&news=n&csc=y&page=toc&d=yrovft&an=00001888-000000000-00000

More information

ANESTHESIOLOGY Comments:

ANESTHESIOLOGY Comments: ANESTHESIOLOGY *Four-week clinical anesthesiology elective Four weeks in subspecialty areas of anesthesiology (cardiovascular, obstetrics, etc.) or research Cardiology Cardiology graphics ICU Infectious

More information

BD-STEP: Tackling Key Issues Across Cancer Research and Care

BD-STEP: Tackling Key Issues Across Cancer Research and Care BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP

More information

The Challenge of Treating Pain

The Challenge of Treating Pain FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and

More information

1 of 9 6/25/17 1:22 AM

1 of 9 6/25/17 1:22 AM News & Perspective Drugs & Diseases CME & Education Academy Consult Video Email This Your Name: Specialty: Emergency Medicine Allergy & Immunology Anesthesiology Business of Medicine Cardiology Critical

More information

CDRH: 510(k)S AND SCIENCE IN REGULATOR DECISION-MAKING. lannery, Scott Danzis and Christopher Pruitt. November 2010 SPECIAL REPRINT

CDRH: 510(k)S AND SCIENCE IN REGULATOR DECISION-MAKING. lannery, Scott Danzis and Christopher Pruitt. November 2010 SPECIAL REPRINT November 2010 SPECIAL REPRINT CDRH: 510(k)S AND SCIENCE IN REGULATOR ORY DECISION-MAKING By Ellen Flanner lannery, Scott Danzis and Christopher Pruitt Reproduced with the kind permission of Global Regulatory

More information

Draft Guidance for Industry and FDA Staff

Draft Guidance for Industry and FDA Staff Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document

More information

AVMED SPECIALIST/SPECIALTIES REQUIRING MEDICARE REFERRAL

AVMED SPECIALIST/SPECIALTIES REQUIRING MEDICARE REFERRAL Addiction Psychiatry Adolescent Medicine (Family Practice) Adolescent Medicine (Pediatric) Adult Congenital Heart Disease Advanced Heart Failure and Transplant Cardiology Aerospace Medicine Allergy & Immunology

More information

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose

More information

SPECIALTY CPT CODES DESCRIPTION

SPECIALTY CPT CODES DESCRIPTION Primary Care Physicians: Internal Medicine, Family Practice, Pediatrics 71010, 71020, 71021, 71022, 71030, 71100, 71101, 71110, 72010, 72020, 72040, 72050, 72052, 72070, 72080, 72100, 72110, 72114, 72170,

More information

Letter to the AMGA Board of Directors...1 Introduction...3

Letter to the AMGA Board of Directors...1 Introduction...3 Table of Contents Letter to the AMGA Board of Directors...1 Introduction...3 Section I: Executive Summary Survey at a Glance...6 Participant Profile...10 Survey Methodology...18 How to Use This Report...21

More information

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike Rockville, MD 20852-1448 September 26, 2011 By Overnight Delivery Michael Dean Berger, M.D.

More information

Collaboration with Cairo University. Cairo University, Faculty of Medicine

Collaboration with Cairo University. Cairo University, Faculty of Medicine Collaboration with Cairo University Cairo University, Faculty of Medicine Kasr Al-Ainy Medical Faculty and Hospital established in 1827 1837, moved to 'Kasr Al-Aini' in Cairo until 1848, graduated 800

More information

Successful collaboration for research development between the NIH and patient organisations

Successful collaboration for research development between the NIH and patient organisations Successful collaboration for research development between the NIH and patient organisations Stephen C. Groft, Pharm.D. Office of Rare Diseases s of Health Department of Health and Human Services EURORDIS

More information

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements CFSAN-FDA General Labeling Provisions FDA s authority to regulate

More information

Emergency Use Authorizations

Emergency Use Authorizations Emergency Use Authorizations May 26, 2016 Quality Improvement Forum Call Celia Hagan, MPH Senior Specialist, Public Policy Overview Emergency Use Authorization (EUA) authority EUA issuance process Zika

More information

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Research That Must Be Reviewed by the IRB

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Research That Must Be Reviewed by the IRB Page: 1 of 5 I. PURPOSE II. III. IV. To provide guidance on the types of research activities that are subject to review and approval by the Committees for the Protection of Human, which comprise the Institutional

More information

2018 Via Hope Peer Services Implementation Learning Community Application Supplement

2018 Via Hope Peer Services Implementation Learning Community Application Supplement 2018 Via Hope Peer Services Implementation Learning Community Application Supplement About the Via Hope Recovery Institute The Via Hope Recovery Institute aims to promote mental health system transformation

More information

National Comprehensive Cancer Control Program Reviewer Training March 16, 2017

National Comprehensive Cancer Control Program Reviewer Training March 16, 2017 FOA DP17-1701 Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations National Comprehensive Cancer Control Program Reviewer Training March 16, 2017 Angela Moore, MPH, Team

More information

Purpose of this Document

Purpose of this Document Guidance on the Procedures for Joint Food Safety and Inspection Service (FSIS) and Food and Drug Administration (FDA) Approval of Ingredients and Sources of Radiation Used in the Production of Meat and

More information

Number of Accredited Programs

Number of Accredited Programs Accredited Academic Year 2016-2017 United States Totals are subject to change during current academic year On-Duty 020 Allergy and immunology 79 306 040 Anesthesiology 150 6,421 041 Adult cardiothoracic

More information

Letter to the AMGA Board of Directors... 1 Introduction... 3

Letter to the AMGA Board of Directors... 1 Introduction... 3 Table of Contents Letter to the AMGA Board of Directors... 1 Introduction... 3 Section I: Executive Summary Survey at a Glance... 6 Participant Profile... 10 Survey Methodology... 19 How to Use This Report...

More information

Regulatory scientific significance of Japan s ADR relief system

Regulatory scientific significance of Japan s ADR relief system Regulatory scientific significance of Japan s ADR relief system Toshi TOMINGA, Ph.D. Associate Executive Director Pharmaceuticals and Medical Devices Agency (PMDA) 1 Disclaimer The views and opinions expressed

More information

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process March 19, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Comments of the Patient, Consumer, and Public Health Coalition on Strengthening

More information

A Purchaser s Guide to Clinical Preventive Services: Moving Science into Coverage

A Purchaser s Guide to Clinical Preventive Services: Moving Science into Coverage A Purchaser s Guide to Clinical Preventive Services: Moving Science into Coverage Overview of a Purchaser s Guide to Clinical Preventive Services A Purchaser s Guide to Clinical Preventive Services: Moving

More information

Neurosurgical Technology and Treatment Techniques

Neurosurgical Technology and Treatment Techniques Update of Neurosurgical Technology and Treatment Techniques Saturday, September 12, 2015 Message from the Chairman I am pleased to invite you to the first Update of Neurosurgical Technology and Treatment

More information

The MGH Journey. Shaping the Future of an Entire Region

The MGH Journey. Shaping the Future of an Entire Region The MGH Journey Shaping the Future of an Entire Region Navigating History, Building on Our Past Northwestern Hospital 1890 First General 1896 St. Luke s 1897 New St. Luke s opens 1915 Northern Michigan

More information

International Pharmaceutical Aerosol Consortium on Regulation and Science

International Pharmaceutical Aerosol Consortium on Regulation and Science International Pharmaceutical Aerosol Consortium on Regulation and Science 1500 K Street NW Washington DC 20005 Telephone +1 202 230 5607 Fax +1 202 842 8465 Email info@ipacrs.org Web www.ipacrs.org Submitted

More information

FELLOWSHIP in CEREBROVASCULAR SURGERY and SKULL BASE SURGERY

FELLOWSHIP in CEREBROVASCULAR SURGERY and SKULL BASE SURGERY FELLOWSHIP in CEREBROVASCULAR SURGERY and SKULL BASE SURGERY Type of Fellowship: Clinical fellowship in cerebrovascular and skull base surgery Supervisors & Teaching Faculty: Dr Prof. David Sinclair, MD,

More information

GUIDELINES FOR SUPERVISION, ROLES, AND RESPONSIBILITIES DURING THE DELIVERY OF OCCUPATIONAL THERAPY SERVICES

GUIDELINES FOR SUPERVISION, ROLES, AND RESPONSIBILITIES DURING THE DELIVERY OF OCCUPATIONAL THERAPY SERVICES GUIDELINES FOR SUPERVISION, ROLES, AND RESPONSIBILITIES DURING THE DELIVERY OF OCCUPATIONAL THERAPY SERVICES This document contains four sections that direct the delivery of occupational therapy services.

More information

Letter to the AMGA Board of Directors... 1 Introduction... 3

Letter to the AMGA Board of Directors... 1 Introduction... 3 Table of Contents Letter to the AMGA Board of Directors... 1 Introduction... 3 Section I: Executive Summary Survey at a Glance... 6 Participant Profile... 10 Survey Methodology... 19 How to Use This Report...

More information

Apostolic Faith Mission of South-Africa Pastors Continuous Development.

Apostolic Faith Mission of South-Africa Pastors Continuous Development. Apostolic Faith Mission of South-Africa Pastors Continuous Development. 1. DEFINITION: Pastors Continuous Development (PCD) is defined as the continuous development of the skills, abilities and character

More information

Overhauling The 510(k) Process

Overhauling The 510(k) Process Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Overhauling The 510(k) Process Law360, New York (August

More information

HEALTH ACCESS NETWORK

HEALTH ACCESS NETWORK Proudly Serving Our Community Since 1947 SAINT LUCIE COUNTY HEALTH ACCESS NETWORK Low Income Pool Assisted Project www.stluciecountyhealth.com 1 A Community-based SYSTEM of Health Services 2 2 History

More information

Mayo Clinic Gynecologic Oncology Fellowship (Minnesota) Competency-based goals

Mayo Clinic Gynecologic Oncology Fellowship (Minnesota) Competency-based goals Mayo Clinic Gynecologic Oncology Fellowship (Minnesota) Competency-based goals 1. PATIENT CARE (includes surgical skills) To train gynecologic oncology fellows to competency in evaluation, treatment and

More information

Date January 20, Contact Information

Date January 20, Contact Information Curriculum Vitae Deborah Golant Badawi, MD Medical Director, Office of Genetics and People with Special Health Care Needs Maryland Department of Health and Mental Hygiene Date January 20, 2016 Contact

More information